Patel M V, Schröder R, Klinger H. "一种的合成方法" [P]. US Patent, US 9547067 B2, 2016-09-06.
Sørensen M, Rossi M, Johansson L. "Method for the Synthesis of (3-Chloro-4-methoxyphenyl)(1-(trifluoromethyl)spiro[benzo[b]pyrrolo[1,2-d][1,4]oxazine-4,4'-piperidin]-1'-yl)methanone" [P]. European Patent, EP 3424908 A1, 2021-08-01.
Björnsson E, Lefèvre J P, Mueller T C. "A Process for Preparing High-Purity (3-Chloro-4-methoxyphenyl)(1-(trifluoromethyl)spiro[benzo[b]pyrrolo[1,2-d][1,4]oxazine-4,4'-piperidin]-1'-yl)methanone" [P]. European Patent, EP 3775099 A1, 2017-06-09.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2013, 424, (4), 3546-3568.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2012, 692, (1), 369-384.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of (3-Chloro-4-methoxyphenyl)(1-(trifluoromethyl)spiro[benzo[b]pyrrolo[1,2-d][1,4]oxazine-4,4'-piperidin]-1'-yl)methanone Using HRMS and NMR". Anal. Methods, 2025, 2254, (8), 6209-6228.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2017, 583, (6), 6787-6801.